Reich & Binstock
Free Initial Consultation
Toll Free: 877-643-3099
Local: 713-352-7883
877-643-3099 713-352-7883

October 2015 Archives

Tylenol maker's legal win not necessarily end of the battle

Back in December, we made note of the fact that the U.S. Food and Drug Administration had raised the volume on its recommendation to reduce dose amounts for patients taking drugs that are combined with an unsafe level of acetaminophen. That's the same pain reliever found in the popular brand Tylenol.

Zofran and birth defects

Pregnant Ultrasound.jpgMothers who used the drug Zofran while pregnant and whose children subsequently were born with birth defects have been coming forward with product liability lawsuits against GlaxoSmithKline, the drug's manufacturer. Anyone else who had this experience may call 1-866-LAW-2400 to get a free consultation as to what her legal options are.

Federal judges take action on morcellator lawsuits

surgeons.jpgSeveral models of a surgical device designed for the treatment of uterine fibroids have been linked to the spread of cancer in patients. Starting this month, many federal product liability lawsuits against one of the makers of these devices will be transferred to a single federal trial court where they will undergo coordinated pretrial proceedings.

Bair Hugger study doesn't bode well as lawsuits filed

Bair_Hugger_Litigation.JPGThere are hip replacement and knee replacement patients nationally who suffer from serious infections seemingly as a result of their exposure to a warming blanket while they underwent the procedure. Now, injured patients are seeking compensation for medical expenses and for other losses. The Bair Hugger is a particular warming device at the center of litigation.

Feds extend comment time on truck safety rule proposal

Regardless of the nature of the issue you are bound to find those who stand on either side of the fence when it comes to federal government rule proposals. On one side are those who feel the government moves too fast or shouldn't move at all. On the other are those who feel the government moves too slowly.

Legal and scientific developments on Pradaxa, Xarelto

Xarelto Vessel Bleed.jpgAs wrongful death and other pharmaceutical injury lawsuits remain pending in regard to the use of two blood thinners, scientists are mercifully closing in on the development of a drug that can stop the bleeding these drugs have been known to cause. The U.S. Food and Drug Administration approved a bleeding stopper for Pradaxa (dabigatran) on Friday. Meanwhile, a drug that would reverse the anticoagulant effects of Xarelto is a little closer to market.

Volkswagen lawsuits filed; executive testifies to Congress

VW-Emissions-Lawsuit.jpgThere are two sides to every coin. One case in point is the Volkswagen debacle, about which a company executive testified before Congress last week. The German automaker has come under fire from federal and California environmental regulators for making several models of vehicles for years that evaded emissions detection, thus diminishing the value of the car and creating a clean air compliance problem for the owners of those vehicles.

Study links CEO pay and unsafe products

The effects of the latest automotive product scandal are only just beginning to unfold. How things will eventually play out in connection with the revelation that Volkswagen software engineers pulled off a hack of sorts is still unclear, but as we recently posted, the fallout is going to be felt quite broadly here in Texas and around the world and affected consumers have a right to seek justice for losses they suffer.

Justice for Volkswagen buyers who've been 'had'

Volkswagen announced that it is cooperating with a probe into the charge that some of its diesel vehicles evaded federal and California clean air standards with software designed to cheat emissions tests. In the meantime, owners of the vehicles involved may call 1-866-LAW-2400 for advice as to how they can protect their rights and be made whole for the diminished resale value of their automobiles and/or for the cost of repairing the emissions malfunction.

FDA expert committee to meet on antibiotics safety

Fluoroquinolone_Lawsuit_Patient.jpgDetermined to get to the bottom of health problems seemingly related to the ingestion of fluoroquinolone antibiotics, the U.S. Food and Drug Administration announced that two of its expert committees will hold a joint meeting about these medications that will be open to the public. The meeting will be held Nov. 5 from 8 a.m. to 6 p.m. at the FDA's Silver Spring, Md., campus.

Clot risk worries with some heart valve implants surprise doctors

Medical devices are big business. They haven't been around for all that long, however. A timeline offered up by the Morgridge Institute for Research suggests that the first such device worthy of bearing the label was the sphygmomanometer, invented in 1881. That's the thing doctors and nurses use to check your blood pressure.

Two years since irreversible nerve damage on Levaquin label

September 2015 marked the second anniversary of the U.S. Food and Drug Administration's stricter warning in regard to the heighted risk of nerve damage associated with the use of the fluoroquinolone antibiotic Levaquin (levofloxacin). What we've known since that label update should have been made known a lot sooner, according to plaintiffs in Levaquin lawsuits, who allege the drug's warnings were inadequate at the time that they used the drug and subsequently were diagnosed with peripheral neuropathy.

Contact Us

Contact Us For Legal Advice

Bold labels are required.

Contact Information

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.


Privacy Policy

4265 San Felipe
Suite 1000
Houston, TX 77027

Toll Free: 877-643-3099
Phone: 713-352-7883
Fax: 713-623-8724
Map & Directions